Compugen presents COM701 ovarian cancer trial poster at ESMO

Go back to Compugen presents COM701 ovarian cancer trial poster at ESMO
Compugen Ltd (NASDAQ: CGEN) Delayed: 2.56 --0 (-0%)
Previous Close $2.56    52 Week High $7.79 
Open $2.56    52 Week Low $4.32 
Day High $2.56    P/E N/A 
Day Low $2.56    EPS $-0.36 
Volume 1,257